Pharmacoeconomics Primer
Planned in cooperation with the ASHP Section of Emerging Sciences Section Advisory Group
ACPE Activity Number: 0204-0000-22-583-H04-P
Release Date: Oct 6, 2022
Expiration Date: Oct 6, 2025
Activity Type: Knowledge-based
CE Credits: 1.5 contact hour, (0.15 CEU)
Activity Fee: Member – Free / Non-Member – Not Available
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Activity Overview
1.5-hour session that includes an overview of pharmacoeconomic principles, methodology, and interpreting cost-effectiveness results to help inform drug policy. Pharmacists will gain valuable knowledge of interpreting and using pharmacoeconomic results to inform formulary and drug policy decisions.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
Learning Objectives
After completing this activity, the learner should be able to…
1. Describe pharmacoeconomic principles including basic terminology, study perspectives and sensitivity analyses.
2. Identify different pharmacoeconomic methodologies, such as cost-effectiveness and cost-utility analyses.
3. Discuss methods to interpret findings from cost-effectiveness analyses including tabular results, graphical scatter-plots, cost-effectiveness acceptability curves (CEACs)
Schedule of Activities
-
Introduction and Announcements
-
Presentation
-
Questions, Answers, and Discussion
Faculty
Professor, University of Utah Skaggs College of Pharmacy
Salt Lake City, Utah
Professor Emeritus, University of Arizona R. Ken Coit College of Pharmacy
Tucson, AZ
Amy Grizzle, PharmD
Associate Director
Center for Health Outcomes & Pharmacoeconomic Research
University of Arizona, R. Ken Coit College of Pharmacy
Tucson, AZ
Jason Hurwitz, PhD
Assistant Director
Center for Health Outcomes & Pharmacoeconomic Research
University of Arizona, R. Ken Coit College of Pharmacy
Tucson, AZ
Moderator: Folashade Alabi, BSPharm, BCCCP
Associate Scientific Director
The Lockwood Group
San Jose, CA
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
-
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Methods and CE Requirements
This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.